Professor | Difei Shen | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Difei Shen
Contact Information	rm000137@whu.edu.cn
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Difei Shen

Contact Information

rm000137@whu.edu.cn

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	1995-2006 Bachelor of Clinical Medicine from Wuhan University 2001-2004 Master of Biomedical Engineering from Wuhan University 2004-2007 PhD in Internal Medicine from Wuhan University Received 2 National Natural Science Foundation grants
Work Experience	2007.08-2011.01 Attending Physician, Lecturer at Renmin Hospital, Wuhan University 2011.01-2012.01 Deputy Chief Physician, Lecturer at Renmin Hospital, Wuhan University 2012.01-2016.12 Associate Professor, Deputy Chief Physician at Renmin Hospital, Wuhan University 2016.12-present Chief Physician, Associate Professor, Assistant Dean at Renmin Hospital, Wuhan University
Awards	2019 Hubei Province Science and Technology Progress First Prize for 'Structural Remodeling and Prevention of Heart Failure' 2013 Hubei Province Science and Technology Progress First Prize for 'Pathogenesis and Clinical Prevention of Cardiac Remodeling'

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

1995-2006 Bachelor of Clinical Medicine from Wuhan University
2001-2004 Master of Biomedical Engineering from Wuhan University
2004-2007 PhD in Internal Medicine from Wuhan University
Received 2 National Natural Science Foundation grants

Work Experience

2007.08-2011.01 Attending Physician, Lecturer at Renmin Hospital, Wuhan University
2011.01-2012.01 Deputy Chief Physician, Lecturer at Renmin Hospital, Wuhan University
2012.01-2016.12 Associate Professor, Deputy Chief Physician at Renmin Hospital, Wuhan University
2016.12-present Chief Physician, Associate Professor, Assistant Dean at Renmin Hospital, Wuhan University

Awards

2019 Hubei Province Science and Technology Progress First Prize for 'Structural Remodeling and Prevention of Heart Failure'
2013 Hubei Province Science and Technology Progress First Prize for 'Pathogenesis and Clinical Prevention of Cardiac Remodeling'

Areas of Focus	Cardiac remodeling Heart failure prevention and treatment
Publications	Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury, Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C, Wu H, Deng W, Shen D, Tang Q, 2020 Geniposide protects against sepsis-induced myocardial dysfunction through AMPKα-dependent pathway, Song P, Shen DF, Meng YY, Kong CY, Zhang X, Yuan YP, Yan L, Tang QZ, Ma ZG, 2020 Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling, Yuan Y, Wang J, Chen Q, Wu Q, Deng W, Zhou H, Shen DF, 2019 Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats, Che Y, Shen DF, Wang ZP, Jin YG, Wu QQ, Wang SS, Yuan Y, 2019 Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy, Wang ZP, Shen DF, Che Y, Jin YG, Wang SS, Wu QQ, Zhou H, Meng YY, Yuan Y, 2019 The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction, Wang J, He W, Guo L, Zhang Y, Li H, Han SX, Shen DF, 2017 The mechanism of TGF-beta/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells, Wang J, He W, Xu X, Guo L, Zhang Y, Han SX, Shen DF, 2017 Shensongyangxin protects against pressure overload induced cardiac hypertrophy, Shen DF, Wu QQ, Ni J, Deng W, Wei C, Jia ZH, Zhou H, Zhou MQ, Bian ZY, Tang QZ, 2016 Shensongyangxin protects cardiomyocytes against LPS-induced injury through the NF kappa B pathway, Shen DF, Ni J, Wu QQ, Deng W, Wei C, Jia ZH, Zhou H, Zhou MQ, Bian ZY, Tang QZ, 2016

Areas of Focus

Cardiac remodeling
Heart failure prevention and treatment

Publications

Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury, Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C, Wu H, Deng W, Shen D, Tang Q, 2020
Geniposide protects against sepsis-induced myocardial dysfunction through AMPKα-dependent pathway, Song P, Shen DF, Meng YY, Kong CY, Zhang X, Yuan YP, Yan L, Tang QZ, Ma ZG, 2020
Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling, Yuan Y, Wang J, Chen Q, Wu Q, Deng W, Zhou H, Shen DF, 2019
Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats, Che Y, Shen DF, Wang ZP, Jin YG, Wu QQ, Wang SS, Yuan Y, 2019
Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy, Wang ZP, Shen DF, Che Y, Jin YG, Wang SS, Wu QQ, Zhou H, Meng YY, Yuan Y, 2019
The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction, Wang J, He W, Guo L, Zhang Y, Li H, Han SX, Shen DF, 2017
The mechanism of TGF-beta/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells, Wang J, He W, Xu X, Guo L, Zhang Y, Han SX, Shen DF, 2017
Shensongyangxin protects against pressure overload induced cardiac hypertrophy, Shen DF, Wu QQ, Ni J, Deng W, Wei C, Jia ZH, Zhou H, Zhou MQ, Bian ZY, Tang QZ, 2016
Shensongyangxin protects cardiomyocytes against LPS-induced injury through the NF kappa B pathway, Shen DF, Ni J, Wu QQ, Deng W, Wei C, Jia ZH, Zhou H, Zhou MQ, Bian ZY, Tang QZ, 2016

Cardiac Remodeling Heart Failure Prevention Treatment Cardiovascular Disease Pathogenesis Clinical

Jianghua Ren - Wuhan University

Zhang Dong - Wuhan University

Ruilin Zhang - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us